230
The Paris Court of Appeal examined, in two separate cases in 2019 and 2021, the lawfulness of the pricing practices of two pharmaceutical groups (Cooper and Bristol-Myers Squibb & UPSA - these last two laboratories were sister companies at that time) with regard to a purchasing pooling (...)